{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:16:18Z","timestamp":1793085378582,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovation Foundation The Danish Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extracellular matrix (ECM) remodeling is a hallmark of the pathology of gastrointestinal disorders. Collagen type VI (COL6) is produced by fibroblasts, and the COL6 \u03b13-chain has shown to be elevated in patients with ulcerative colitis (UC), Crohn\u2019s disease (CD) and colorectal cancer (CRC). Measuring COL6\u03b13 in serum may therefore have potential as a biomarker for gastrointestinal disorders. The aims of this study were to develop and validate a competitive ELISA targeting a specific neo-epitope of COL6\u03b13 and evaluate its associations with the gastrointestinal disorders UC, CD and CRC, in comparison to healthy controls. A monoclonal antibody was raised against a matrix metalloproteinase-2 and -9 specific cleavage site of COL6\u03b13 (C6M\u03b13) and employed in a competitive enzyme-linked immunosorbent assay (ELISA). The assay was developed and technically validated. Levels of C6M\u03b13 were measured in serum from patients with UC (n\u2009=\u200958), CD (n\u2009=\u200944) and CRC (n\u2009=\u200939) and compared to healthy controls (n\u2009=\u200932). The levels of C6M\u03b13 were elevated in patients with UC, CD and CRC patients compared to healthy controls (all p\u2009&lt;\u20090.0001). The area under the receiver operating characteristics (AUROC) curve for separation of patients with UC from healthy controls was 0.972 (95% CI: 0.925\u20131.020, p\u2009&lt;\u20090.0001), with CD from healthy controls was 0.947 (95% CI: 0.885\u20131.009, p\u2009&lt;\u20090.0001) and with CRC from healthy controls was 0.890 (95% CI: 0.809\u20130.972, p\u2009&lt;\u20090.0001). We developed a technically robust assay targeting a fragment of COL6, which was elevated in serum from patients with UC, CD and CRC.<\/jats:p>","DOI":"10.1038\/s41598-020-62474-1","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:06:32Z","timestamp":1585908392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-1014","authenticated-orcid":false,"given":"Signe","family":"Holm Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H\u00f8g","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Willumsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-7482","authenticated-orcid":false,"given":"Daniel Guldager Kring","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte J.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Nannestad","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Klinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Julie","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"62474_CR1","doi-asserted-by":"publisher","unstructured":"Shimshoni, E., Yablecovitch, D., Baram, L., Dotan, I. & Sagi, I. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation., https:\/\/doi.org\/10.1136\/gutjnl-2014-308048.","DOI":"10.1136\/gutjnl-2014-308048"},{"key":"62474_CR2","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham, C. & Cho, J. H. Inflammatory Bowel Disease. N. Engl. J. Med. 361, 2066\u20132078 (2009).","journal-title":"N. Engl. J. Med."},{"key":"62474_CR3","doi-asserted-by":"publisher","unstructured":"Mortensen, J. H. et al. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn\u2019s Disease from Ulcerative Colitis. J. Crohn\u2019s Colitis jjv123, https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv123 (2015).","DOI":"10.1093\/ecco-jcc\/jjv123"},{"key":"62474_CR4","first-page":"1","volume":"12","author":"JH Mortensen","year":"2017","unstructured":"Mortensen, J. H. et al. Ulcerative colitis, Crohn\u2019s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn\u2019s disease. Plos one 12, 1\u201316 (2017).","journal-title":"Plos one"},{"key":"62474_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10620-017-4892-4","volume":"63","author":"P Giuffrida","year":"2018","unstructured":"Giuffrida, P., Corazza, G. R. & Di Sabatino, A. Old and New Lymphocyte Players in Inflammatory Bowel Disease. Dig. Dis. Sci. 63, 277\u2013288 (2018).","journal-title":"Dig. Dis. Sci."},{"key":"62474_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep30599","volume":"6","author":"SN Kehlet","year":"2016","unstructured":"Kehlet, S. N. et al. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients. Sci. Rep. 6, 30599 (2016).","journal-title":"Sci. Rep."},{"key":"62474_CR7","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1242\/jcs.169748","volume":"128","author":"M Cescon","year":"2015","unstructured":"Cescon, M., Gattazzo, F., Chen, P. & Bonaldo, P. Collagen VI at a glance. J. Cell Sci. 128, 3525\u20133531 (2015).","journal-title":"J. Cell Sci."},{"key":"62474_CR8","doi-asserted-by":"crossref","unstructured":"Kuo, H.-J., Maslen, C. L., Keene, D. R. & Glanville, R. W. Type VI Collagen Anchors Endothelial Basement Membranes by Interacting with Type IV Collagen* Downloaded from. THE Journal of Biological Chemistry 272, (1997).","DOI":"10.1074\/jbc.272.42.26522"},{"key":"62474_CR9","doi-asserted-by":"crossref","unstructured":"LeBleu, V. S. & Kalluri, R. A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis. Model. Mech. 11, dmm029447 (2018).","DOI":"10.1242\/dmm.029447"},{"key":"62474_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786\u2013801 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62474_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161\u2013174 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"62474_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.molmed.2013.04.001","volume":"19","author":"P Chen","year":"2013","unstructured":"Chen, P., Cescon, M. & Bonaldo, P. Collagen VI in cancer and its biological mechanisms. Trends Mol. Med. 19, 410\u2013417 (2013).","journal-title":"Trends Mol. Med."},{"key":"62474_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MOG.0000000000000042","volume":"30","author":"P Giuffrida","year":"2014","unstructured":"Giuffrida, P., Biancheri, P. & MacDonald, T. T. Proteases and small intestinal barrier function in health and disease. Curr. Opin. Gastroenterol. 30, 147\u2013153 (2014).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"62474_CR14","doi-asserted-by":"crossref","first-page":"29929","DOI":"10.18632\/oncotarget.4966","volume":"6","author":"J Qiao","year":"2015","unstructured":"Qiao, J. et al. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics. Oncotarget 6, 29929\u201346 (2015).","journal-title":"Oncotarget"},{"key":"62474_CR15","first-page":"2527","volume":"39","author":"L Wei","year":"2018","unstructured":"Wei, L., Li, L., Hua, Y., Huan, T. & Huaqin, H. Role of COL6A3 in colorectal cancer. Oncol. Rep. 39, 2527\u20132536 (2018).","journal-title":"Oncol. Rep."},{"key":"62474_CR16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.18632\/oncotarget.796","volume":"33","author":"J Park","year":"2012","unstructured":"Park, J. & Scherer, P. E. Endotrophin \u2013 Linking Obesity with Aggressive Tumor Growth. Oncotarget 33, 1487\u20131488 (2012).","journal-title":"Oncotarget"},{"key":"62474_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1535-6108(03)00058-8","volume":"3","author":"CA Sherman-Baust","year":"2003","unstructured":"Sherman-Baust, C. A. et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell 3, 377\u2013386 (2003).","journal-title":"Cancer Cell"},{"key":"62474_CR18","first-page":"925","volume":"14","author":"RR Varma","year":"2005","unstructured":"Varma, R. R. et al. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780\/C10. Oncol. Rep. 14, 925\u2013932 (2005).","journal-title":"Oncol. Rep."},{"key":"62474_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI23424","volume":"115","author":"P Iyengar","year":"2005","unstructured":"Iyengar, P. et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor\/stroma microenvironment. J. Clin. Invest. 115, 1163\u20131176 (2005).","journal-title":"J. Clin. Invest."},{"key":"62474_CR20","doi-asserted-by":"publisher","first-page":"1700164","DOI":"10.1002\/pmic.201700164","volume":"17","author":"M Moriggi","year":"2017","unstructured":"Moriggi, M. et al. Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study. Proteomics 17, 1700164 (2017).","journal-title":"Proteomics"},{"key":"62474_CR21","doi-asserted-by":"crossref","unstructured":"Kirov, S. et al. Degradation of the extracellular matrix is part of the pathology of ulcerative colitis. 1\u201326 (2018).","DOI":"10.1101\/412684"},{"key":"62474_CR22","doi-asserted-by":"publisher","unstructured":"Haaften, W. T. V et al. Misbalance in type III collagen formation\/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn\u2019 s disease. Aliment. Pharmacol. Ther. 26\u201339, https:\/\/doi.org\/10.1111\/apt.14092 (2017).","DOI":"10.1111\/apt.14092"},{"key":"62474_CR23","doi-asserted-by":"publisher","first-page":"e24753","DOI":"10.1371\/journal.pone.0024753","volume":"6","author":"SS Veidal","year":"2011","unstructured":"Veidal, S. S. et al. MMP mediated degradation of type VI collagen is highly associated with liver fibrosis\u2013identification and validation of a novel biochemical marker assay. Plos one 6, e24753 (2011).","journal-title":"Plos one"},{"key":"62474_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF01551818","volume":"3","author":"ML Gefter","year":"1977","unstructured":"Gefter, M. L., Margulies, D. H. & Scharff, M. D. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet. 3, 231\u20136 (1977).","journal-title":"Somatic Cell Genet."},{"key":"62474_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/apt.14092","volume":"46","author":"WT van Haaften","year":"2017","unstructured":"van Haaften, W. T. et al. Misbalance in type III collagen formation\/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn\u2019s disease. Aliment. Pharmacol. Ther. 46, 26\u201339 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"62474_CR26","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1200\/JCO.2018.36.15_suppl.3588","volume":"36","author":"SN Kehlet","year":"2018","unstructured":"Kehlet, S. N. et al. Prognostic evaluation of a new class of liquid biopsy biomarkers in patients with metastatic colorectal cancer: Using the tumor microenvironment as a source of protein biomarkers. J. Clin. Oncol. 36, 3588 (2018).","journal-title":"J. Clin. Oncol."},{"key":"62474_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11605-013-2326-y","volume":"18","author":"CY Kang","year":"2014","unstructured":"Kang, C. Y. et al. Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma. J. Gastrointest. Surg. 18, 7\u201315 (2014).","journal-title":"J. Gastrointest. Surg."},{"key":"62474_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","volume":"3","author":"RG Jenkins","year":"2015","unstructured":"Jenkins, R. G. et al. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: An analysis from the prospective, multicentre PROFILE study. Lancet Respir. Med. 3, 462\u2013472 (2015).","journal-title":"Lancet Respir. Med."},{"key":"62474_CR29","doi-asserted-by":"crossref","unstructured":"Leeming, D. J. et al. A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M) A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbe. 5804 (2011).","DOI":"10.3109\/1354750X.2011.620628"},{"key":"62474_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s13539-013-0114-x","volume":"4","author":"A Nedergaard","year":"2013","unstructured":"Nedergaard, A. et al. Type VI collagen turnover-related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young men. J. Cachexia. Sarcopenia Muscle 4, 267\u2013275 (2013).","journal-title":"J. Cachexia. Sarcopenia Muscle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62474-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:28:23Z","timestamp":1670318903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62474-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62474"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62474-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.H.N., J.H.M., N.W., D.J.L., M.A.K. and F.G. are full-time employees at Nordic Bioscience. Nordic, Bioscience is a privately-owned, small\u2013medium size enterprise partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. D.J.L., M.A.K. and F.G. holds stocks in Nordic Bioscience. The patent for the ELISA used to assess C6M\u03b13 levels is owned by Nordic Bioscience. The funder provided support in the form of salaries for authors D.G.K.R., M.A.K. and F.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors report no competing financial interests relevant to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5910"}}